MOTS-c vs NAD+

Two cellular-energy research compounds. Here is how the two research peptides compare on class, format and price.

MOTS-c

MOTS-c is a mitochondrial-derived peptide encoded within the mitochondrial genome. It is supplied lyophilised in a 10 mg vial for laboratory and in-vitro research use only.

MOTS-c is studied for its role in metabolic regulation, AMPK signalling and cellular-stress response in longevity and metabolic research.

NAD+

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme central to cellular energy metabolism, supplied lyophilised in a 500 mg vial for laboratory and in-vitro research use only.

NAD+ is studied for its role in redox reactions, sirtuin activity and cellular-energy and ageing research.

Which do researchers choose?

MOTS-c and NAD+ are two cellular-energy research compounds. The right choice depends on the research question: they differ in class (Mitochondrial-derived peptide vs Nicotinamide adenine dinucleotide) and strength (10 mg vs 500 mg). Both are supplied lyophilised, third-party HPLC tested, and shipped express post Australia-wide for laboratory and in-vitro research use only.

Frequently asked questions